We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWR
1526
DELISTED
New Relic, Inc.
NEWR
| $3.17M | 0.01% |
48,171
+1,499
| +3% | +$97.4K |
|
1527
Artivion
AORT
$1.27B
| $3.16M | 0.01% |
116,667
+6,394
| +6% | +$157K |
|
|
BMCH
1528
DELISTED
BMC Stock Holdings, Inc
BMCH
| $3.16M | 0.01% |
110,171
+2,076
| +2% | +$58.4K |
|
1529
Kulicke & Soffa
KLIC
$4.91B
| $3.15M | 0.01% |
115,992
+8,927
| +8% | +$220K |
|
|
TVTY
1530
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $3.15M | 0.01% |
155,051
+7,410
| +5% | +$139K |
|
|
UCTT
1531
Ultra Clean Holdings
UCTT
$3.6B
| $3.15M | 0.01% |
134,355
+8,058
| +6% | +$163K |
|
1532
Hilltop Holdings
HTH
$2.28B
| $3.15M | 0.01% |
126,313
+8,198
| +7% | +$200K |
|
|
WBT
1533
DELISTED
Welbilt, Inc.
WBT
| $3.15M | 0.01% |
201,612
+9,525
| +5% | +$163K |
|
1534
Varonis Systems
VRNS
$4.98B
| $3.14M | 0.01% |
121,137
+3,066
| +3% | +$72.8K |
|
1535
Designer Brands
DBI
$339M
| $3.13M | 0.01% |
198,899
+8,156
| +4% | +$135K |
|
1536
Children's Place
PLCE
$58M
| $3.13M | 0.01% |
49,989
+3,087
| +7% | +$225K |
|
|
MTSC
1537
DELISTED
MTS Systems Corp
MTSC
| $3.12M | 0.01% |
65,023
+2,810
| +5% | +$149K |
|
|
CIR
1538
DELISTED
CIRCOR International, Inc
CIR
| $3.12M | 0.01% |
67,438
+3,196
| +5% | +$132K |
|
1539
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $3.12M | 0.01% |
84,144
+1,381
| +2% | +$46.1K |
|
1540
E.W. Scripps
SSP
$263M
| $3.11M | 0.01% |
198,217
+9,140
| +5% | +$130K |
|
|
POLY
1541
DELISTED
Plantronics, Inc.
POLY
| $3.11M | 0.01% |
113,869
+5,458
| +5% | +$164K |
|
1542
Towne Bank
TOWN
$3.5B
| $3.1M | 0.01% |
111,522
+2,254
| +2% | +$63.2K |
|
|
EPZM
1543
DELISTED
Epizyme, Inc
EPZM
| $3.1M | 0.01% |
126,048
+3,646
| +3% | +$54.1K |
|
1544
Pegasystems
PEGA
$5.23B
| $3.09M | 0.01% |
77,582
+964
| +1% | +$36.5K |
|
|
ARQL
1545
DELISTED
Arqule Inc
ARQL
| $3.09M | 0.01% |
154,703
+5,878
| +4% | +$68.2K |
|
1546
News Corp Class B
NWS
$17.9B
| $3.07M | 0.01% |
211,599
+15,256
| +8% | +$210K |
|
|
CIM
1547
Chimera Investment
CIM
$991M
| $3.07M | 0.01% |
49,725
+316
| +0.6% | +$19.3K |
|
1548
Otter Tail
OTTR
$3.9B
| $3.06M | 0.01% |
59,735
+995
| +2% | +$51.6K |
|
|
CLDT
1549
Chatham Lodging
CLDT
$625M
| $3.06M | 0.01% |
167,036
+10,944
| +7% | +$197K |
|
1550
First Hawaiian
FHB
$3.38B
| $3.06M | 0.01% |
106,133
+589
| +0.6% | +$16.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.